Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma (Q43265079)
Jump to navigation
Jump to search
scientific article published in November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma |
scientific article published in November 2009 |
Statements
1 reference
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma (English)
1 reference
Pier Luigi Zinzani
1 reference
Michele Baccarani
1 reference
Stefano A Pileri
1 reference
Amalia De Renzo
1 reference
Vittorio Stefoni
1 reference
Cinzia Pellegrini
1 reference
Maria Paola Fina
1 reference
Alessandro Broccoli
1 reference
Filippo Venturini
1 reference
Letizia Gandolfi
1 reference
Maurizio Martelli
1 reference
Maria Concetta Petti
1 reference
Alessio Perrotti
1 reference
Francesco Zaja
1 reference
1 November 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference